Acura Pharmaceuticals, Inc. (ACUR)

Market Cap	26.40K
Revenue (ttm)	1.56M
Net Income (ttm)	-1.08M
Shares Out	66.00M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	262
Open	0.0004
Previous Close	0.0004
Day's Range	0.0004 - 0.0004
52-Week Range	0.0002 - 0.1000
Beta	2.21
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 28, 2020

About ACUR

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1935
• Employees: 9
• Stock Exchange: OTCMKTS
• Ticker Symbol: ACUR

Financial Performance

In 2021, ACUR's revenue was $1.56 million, a decrease of -56.22% compared to the previous year's $3.57 million. Losses were -$1.08 million, -34.92% less than in 2020.